BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

RK-023: Phase I amended

R-Tech said it discontinued the U.K. portion of a double-blind, placebo-controlled Japanese and U.K. Phase I trial evaluating twice-daily RK-023 applied to the eyelid margin...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >